(Q35681513)

9 August 2017

1 reference

title

Effectiveness of live varicella vaccine (English)

1 reference

9 August 2017

Michiaki Takahashi

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Expert Opinion on Biological Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

199-216

1 reference

Immunisation against chickenpox

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Risks and benefits of varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Antibody assays suitable for assessing immune responses to live varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Lymphocyte responses to varicella zoster virus in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Clinical application of responder cell frequency estimates with four years of follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Diagnostic Skin Test Reactions with Varicella Virus Antigen and Clinical Application of the Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Soluble Skin Test Antigen of Varicella-Zoster Virus Prepared from the Fluid of Infected Cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Varicella vaccine: genesis, efficacy, and attenuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Live vaccine used to prevent the spread of varicella in children in hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Immunization of healthy adults with live attenuated varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

A long-term prospective study of varicella vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Varicella outbreaks after vaccine licensure: should they make you chicken?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Postlicensure study of varicella vaccine effectiveness in a day-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Outbreaks in highly vaccinated populations: implications for studies of vaccine performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Postlicensure safety surveillance for varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Imaging of the varicella zoster virion in the viral highways: comparison with herpes simplex viruses 1 and 2, cytomegalovirus, pseudorabies virus, and human herpes viruses 6 and 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Cost-effectiveness of a routine varicella vaccination program for US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

An economic analysis of varicella vaccination for health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

The cost-effectiveness of varicella vaccine programs for Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

An Outbreak of Varicella among children attending preschool and elementary school in Illinois

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.199

21 January 2018

Identifiers

DOI

10.1517/14712598.4.2.199

1 reference

9 August 2017

1 reference